Author

Sugrah Sultan

Institution: Birmingham Women’s and Children’s NHS Foundation Trust

Observed institution: Birmingham Women’s and Children’s NHS Foundation Trust

OpenAlex ID: A5086093531

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 560

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

2022 · Simeng Lin, Nicholas A. Kennedy, et al. · Nature Communications · 103

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

2022 · Zhigang Liu, Kaixing Le, et al. · The Lancet. Gastroenterology & hepatology · 35

Synovial tissue atlas in juvenile idiopathic arthritis reveals pathogenic niches associated with disease severity

2025 · Chrissy Bolton, Christopher B. Mahony, et al. · Science Translational Medicine · 31

Minimally invasive, ultrasound-guided synovial tissue biopsies are well-tolerated, safe and feasible in children and young people with inflammatory arthritis

2026 · Elizabeth Clay, Chrissy Bolton, et al. · RMD Open

Works count: 5

Citation count: 729

H-index: 4

I10-index: 4